Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New reactions in clavulanic acid biosynthesis.

Craig A Townsend1

  • 1Department of Chemistry, The Johns Hopkins University, 3400 North Charles Street, Baltimore, MD 21218, USA. ctownsend@jhu.edu

Current Opinion in Chemical Biology
|November 5, 2002
PubMed
Summary

Clavulanic acid shows modest antibiotic effects but strongly inhibits bacterial resistance enzymes. Its complex biosynthesis reveals unique biochemical reactions, unlike related antibiotics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural Basis for 3-Amino-3-carboxypropyl Transfer in Nocardicin Biosynthesis.

Journal of the American Chemical Society·2025
Same author

Sequential Reconstruction of Calicheamicin γ<sub>1</sub> <sup>I</sup> Iodo-Thiobenzoate by Selective Carrier Protein Trapping Reveals a Flavin-Dependent Iodinase.

Angewandte Chemie (International ed. in English)·2025
Same author

l-2,3-Diaminopropionate Binding Mode of the SulM Adenylation Domain Limits Engineering Monobactam Analogue Biosynthesis with Larger Substrates.

JACS Au·2025
Same author

Dynemicin A Derivatives as Potential Cancer Chemotherapeutics by Mutasynthesis.

Helvetica chimica acta·2024
Same author

The structure of the monobactam-producing thioesterase domain of SulM forms a unique complex with the upstream carrier protein domain.

The Journal of biological chemistry·2024
Same author

The structure of the monobactam-producing thioesterase domain of SulM forms a unique complex with the upstream carrier protein domain.

bioRxiv : the preprint server for biology·2024

Area of Science:

  • Biochemistry
  • Microbiology
  • Drug Discovery

Background:

  • Clavulanic acid is a beta-lactamase inhibitor, crucial for combating bacterial resistance.
  • Bacterial resistance, particularly via beta-lactamase enzymes, poses a significant threat to antibiotic efficacy.
  • Understanding clavulanic acid's properties is vital for developing new strategies against resistant bacteria.

Purpose of the Study:

  • To investigate the complex biosynthetic pathway of clavulanic acid.
  • To identify and understand the novel enzymatic reactions involved in clavulanic acid synthesis.
  • To compare the biosynthetic complexity of clavulanic acid with related beta-lactam antibiotics.

Main Methods:

  • Analysis of the clavulanic acid biosynthetic pathway.
  • Enzymatic assays to study specific reactions.
  • Comparative analysis with penicillin and cephalosporin biosynthesis.

Main Results:

  • The biosynthetic pathway of clavulanic acid is significantly more complex than those of penicillins and cephalosporins.
  • Several novel and interesting enzymatic reactions were identified within the clavulanic acid pathway.
  • Clavulanic acid's modest direct antibiotic activity is contrasted by its potent enzyme inhibition.

Conclusions:

  • The intricate biosynthesis of clavulanic acid offers insights into novel biochemical processes.
  • Further research into these reactions could lead to the development of new antibacterial agents or resistance-breaking strategies.
  • The complexity highlights unique evolutionary or biochemical pathways for antibiotic production.

Related Experiment Videos